GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.
Primary endpoint met in phase 2a POC trial in postpartum depression with a MADRS reduction from baseline of –35.4 points (p<0.0001, n=10) and 100% of patients in remission at Day 8Primary...
Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 clinical trial to evaluate proprietary aerosol...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.268 | -2.8972972973 | 9.25 | 9.33 | 8.55 | 70799 | 8.87716799 | CS |
4 | 1.482 | 19.76 | 7.5 | 10.23 | 6.95 | 96952 | 8.55426706 | CS |
12 | 0.882 | 10.8888888889 | 8.1 | 11.09 | 6.72 | 75708 | 8.55934315 | CS |
26 | -3.618 | -28.7142857143 | 12.6 | 14 | 6 | 59511 | 8.50452287 | CS |
52 | 1.652 | 22.5375170532 | 7.33 | 14.99 | 6 | 73699 | 9.55792547 | CS |
156 | -7.178 | -44.4183168317 | 16.16 | 21.32 | 5.05 | 72707 | 10.36907118 | CS |
260 | -13.018 | -59.1727272727 | 22 | 30.43 | 5.05 | 81307 | 13.24730832 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.